PET imaging as a tool for assessing COVID-19 brain changes

Please use this identifier to cite or link to this item: http://repositorio.ufla.br/jspui/handle/1/43606

metadata.artigo.dc.title:	PET imaging as a tool for assessing COVID-19 brain changes
metadata.artigo.dc.creator:	Fontana, Igor C. Bongarzone, Salvatore Gee, Antony Souza, Diogo O. Zimmer, Eduardo R.
metadata.artigo.dc.subject:	Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) COVID-19 - Neurological manifestations Positron Emission Tomography (PET) radiotracers
metadata.artigo.dc.publisher:	Elsevier
metadata.artigo.dc.date.issued:	2020
metadata.artigo.dc.identifier.citation:	FONTANA, I. C. et al. PET imaging as a tool for assessing COVID-19 brain changes. Trends in Neurosciences, [S.l.], 2020. No prelo.
metadata.artigo.dc.description.abstract:	A substantial fraction of coronavirus disease 2019 (COVID-19) patients experience neurological manifestations. Nevertheless, brain changes caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remain largely unknown. Here, we provide a brief overview of positron emission tomography (PET) applications that could advance current understanding of CNS pathophysiological alterations associated with SARS-CoV-2 infection.
metadata.artigo.dc.identifier.uri:	https://www.sciencedirect.com/science/article/pii/S0166223620302435 http://repositorio.ufla.br/jspui/handle/1/43606
metadata.artigo.dc.language:	en_US
Appears in Collections:	FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19)

Files in This Item:

There are no files associated with this item.